Bone induction in nonhuman primates. An experimental study on the baboon.
Development leading to local bone differentiation in response to intramuscular and subcutaneous implantation of demineralized bone matrix has been predominantly investigated in rodents. To investigate bone differentiation by induction in primates, diaphyseal bone was harvested from ten male baboons and chemosterilized to obtain autolyzed, antigen-extracted allogeneic (AAA) bone containing the bone morphogenetic protein essential for osteoinduction. A total of 96 AAA bone diaphyseal cylinders were implanted intramuscularly in 24 adult male baboons and harvested at three, six, and nine months. Histologic analysis showed that the matrix had undergone considerable resorption, particularly at six and nine months. Seventy-three implants showed variable amounts of newly formed bone at the internal and external surfaces of the chemosterilized matrix. Numerous specimens showed florid bone formation, and newly formed woven bone persisted in association with the matrix for as long as nine months. Coating the AAA bone matrix with an allogeneic fibrin-fibronectin protein concentrate prepared from fresh-frozen baboon plasma did not significantly increase the amount of induced bone. Bone formation was confirmed by intravital double tetracycline labeling of the mineralization fronts. The unequivocal demonstration of bone formation by induction in a large series of adult nonhuman primates provides evidence that long-lived higher vertebrates retain the bone-inductive proteins in the extracellular matrix of bone and the crucial set of responding mesenchymal cells capable of transformation and differentiation into osteoblastic cell lines.
Ripamonti
U
U
Medical Research Council, Johannesburg, South Africa.
D000818:Animals; D001857:Bone Matrix / Q000033:anatomy & histology / Q000187:drug effects* / Q000502:physiology; D019485:Bone Morphogenetic Proteins; D016025:Bone Transplantation; D005109:Extracellular Matrix / Q000187:drug effects; D005337:Fibrin / Q000494:pharmacology*; D005353:Fibronectins / Q000494:pharmacology*; D006133:Growth Substances / Q000502:physiology*; D008297:Male; D010012:Osteogenesis / Q000187:drug effects*; D010215:Papio; D011506:Proteins / Q000502:physiology*
D019485:Bone Morphogenetic Proteins; D005353:Fibronectins; D006133:Growth Substances; D011506:Proteins; D005337:Fibrin